Oxymorphone (oxymorphone HCl)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Oxymorphone hydrochloride is a semisynthetic phenanthrene-derivative opiate agonist.
Oxymorphone hydrochloride is a strong analgesic used in the relief of moderate to severe pain. The drug is also used parenterally as a supplement to anesthesia and for analgesia during labor. Oxymorphone is used in patients with pulmonary edema for its cardiovascular effects and to allay anxiety.
The drug should not be used in the treatment of pulmonary edema resulting from a chemical respiratory irritant.
Generic name: oxymorphone HCl
Pronunciation: (OX-i-MOR-fone)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Oxymorphone
Indications
The following indications are listed for Oxymorphone:
- Severe Chronic Pain Requiring Long-Term Opioid Treatment
Dosing
Oxymorphone hydrochloride should be given at the lowest effective dosage and for the shortest duration of therapy consistent with the treatment goals of the patient. Reduced dosage is indicated in poor-risk patients and in geriatric patients. If concomitant therapy with other CNS depressants is required, the lowest effective dosages and shortest possible duration of concomitant therapy should be used.
The manufacturer recommends that initial dosages of 33-50% of the usual dosage be employed when therapy with oxymorphone hydrochloride is initiated in patients receiving other CNS depressants.
For acute pain not related to trauma or surgery, the prescribed quantity should be limited to the amount needed for the expected duration of pain severe enough to require opiate analgesia (generally 3 days or less and rarely more than 7 days). When opiate analgesics are used for the management of chronic noncancer pain, the US Centers for Disease Control and Prevention (CDC) recommends that primary care clinicians carefully reassess individual benefits and risks before prescribing dosages equivalent to 50 mg or more of morphine sulfate daily (approximately 17 mg or more of oxymorphone hydrochloride daily) and avoid dosages equivalent to 90 mg or more of morphine sulfate daily (approximately 30 mg or more of oxymorphone hydrochloride daily) or carefully justify their decision to titrate the dosage to such levels. Other experts recommend consulting a pain management specialist before exceeding a dosage equivalent to 80-120 mg of morphine sulfate daily. For further information on the management of opiate analgesic therapy, see Dosage and Administration: Dosage, in the Opiate Agonists General Statement 28:08.08.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.